Cargando…

Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrosing interstitial lung disease that occurs predominantly in the older population. There is increasing incidence and prevalence in IPF globally. The emergence of anti-fibrotic therapies in the last decade have improved patient surv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thong, Lorraine, McElduff, Enda James, Henry, Michael Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963632/ https://www.ncbi.nlm.nih.gov/pubmed/36836843 http://dx.doi.org/10.3390/life13020486

Ejemplares similares

Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential
por: Raghu, Ganesh
Publicado: (2017)

Update on diagnosis and treatment of idiopathic pulmonary fibrosis
por: Baddini-Martinez, José, et al.
Publicado: (2015)

Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis
por: Davidsen, Jesper Rømhild, et al.
Publicado: (2020)

Update on therapeutic management of idiopathic pulmonary fibrosis
por: Tzouvelekis, Argyris, et al.
Publicado: (2015)

Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update
por: Rodríguez-Portal, José Antonio
Publicado: (2017)

Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis
por: Gulati, Swati, et al.
Publicado: (2020)

Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
por: Mei, Qianru, et al.
Publicado: (2022)

Molecular pathways in idiopathic pulmonary fibrosis pathogenesis: Transcending barriers to optimally targeted pharmacotherapies
por: Strykowski, Rachel, et al.
Publicado: (2021)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Insulin Detemir in Pregnancy: A Small but Significant Step Forward?
por: McElduff, Aidan
Publicado: (2012)

Comment on: Au et al. Body Composition Is Normal in Term Infants Born to Mothers With Well-Controlled Gestational Diabetes Mellitus. Diabetes Care 2013;36:562–564
por: McElduff, Aidan
Publicado: (2013)

Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011)

Idiopathic Pulmonary Fibrosis: Treatment and Prognosis
por: Fujimoto, Hajime, et al.
Publicado: (2016)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Regression to the mean and alcohol consumption: A cohort study exploring implications for the interpretation of change in control groups in brief intervention trials()
por: McCambridge, Jim, et al.
Publicado: (2014)

Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics Concluding remarks
por: Costabel, Ulrich
Publicado: (2013)

Update on Pharmacotherapy in Psychodermatological Disorders
por: Shenoi, Shrutakirthi D., et al.
Publicado: (2020)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

The changing treatment landscape in idiopathic pulmonary fibrosis
por: Costabel, Ulrich
Publicado: (2015)

Update on the pharmacotherapy of cerebellar and central vestibular disorders
por: Kalla, Roger, et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis: Current and future treatment
por: Glass, Daniel S., et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis: current diagnosis and treatment
por: Amaral, Alexandre Franco, et al.
Publicado: (2023)

Epidemiology of idiopathic pulmonary fibrosis
por: Ley, Brett, et al.
Publicado: (2013)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Idiopathic Pulmonary Fibrosis and Telomeres
por: Mulet, Alba, et al.
Publicado: (2022)

Treatment of Idiopathic Pulmonary Fibrosis
por: Abuserewa, Sherif T, et al.
Publicado: (2021)

Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update
por: James, Cornelius Fernandez, et al.
Publicado: (2022)

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
por: Wollin, Lutz, et al.
Publicado: (2015)

Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
por: Chen, I-Chen, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis in 2011: key updates on guidelines and therapeutics
por: Costabel, U, et al.
Publicado: (2013)

Updates in the New Guidelines for Idiopathic Pulmonary Fibrosis: Role of Cryobiopsy
por: Cascante Rodrigo, Jose Antonio, et al.
Publicado: (2022)

Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study
por: Barker, Daniel, et al.
Publicado: (2017)

Coagulation and anticoagulation in idiopathic pulmonary fibrosis
por: Crooks, Michael G., et al.
Publicado: (2015)

Update on pharmacotherapy for ocular surface squamous neoplasia
por: Al Bayyat, Ghada, et al.
Publicado: (2019)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Management of Idiopathic Pulmonary Fibrosis
por: Pleasants, Roy, et al.
Publicado: (2019)

Stepped wedge cluster randomised trials: a review of the statistical methodology used and available
por: Barker, D., et al.
Publicado: (2016)

Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis
por: Kou, Leiya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cpmuuqvto978ve55mpvgj7l5ku